JAZZ
Price
$100.50
Change
-$1.55 (-1.52%)
Updated
Apr 11 closing price
Capitalization
6.1B
18 days until earnings call
TPST
Price
$6.22
Change
+$0.36 (+6.14%)
Updated
Apr 11 closing price
Capitalization
21.9M
26 days until earnings call
Ad is loading...

JAZZ vs TPST

Header iconJAZZ vs TPST Comparison
Open Charts JAZZ vs TPSTBanner chart's image
Jazz Pharmaceuticals
Price$100.50
Change-$1.55 (-1.52%)
Volume$1.71M
Capitalization6.1B
Tempest Therapeutics
Price$6.22
Change+$0.36 (+6.14%)
Volume$113.32K
Capitalization21.9M
JAZZ vs TPST Comparison Chart
Loading...
JAZZ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TPST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
JAZZ vs. TPST commentary
Apr 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JAZZ is a Hold and TPST is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 12, 2025
Stock price -- (JAZZ: $100.50 vs. TPST: $6.22)
Brand notoriety: JAZZ and TPST are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: JAZZ: 134% vs. TPST: 176%
Market capitalization -- JAZZ: $6.1B vs. TPST: $21.9M
JAZZ [@Biotechnology] is valued at $6.1B. TPST’s [@Biotechnology] market capitalization is $21.9M. The market cap for tickers in the [@Biotechnology] industry ranges from $266.66B to $0. The average market capitalization across the [@Biotechnology] industry is $1.98B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

JAZZ’s FA Score shows that 0 FA rating(s) are green whileTPST’s FA Score has 0 green FA rating(s).

  • JAZZ’s FA Score: 0 green, 5 red.
  • TPST’s FA Score: 0 green, 5 red.
According to our system of comparison, TPST is a better buy in the long-term than JAZZ.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

JAZZ’s TA Score shows that 4 TA indicator(s) are bullish while TPST’s TA Score has 4 bullish TA indicator(s).

  • JAZZ’s TA Score: 4 bullish, 6 bearish.
  • TPST’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, TPST is a better buy in the short-term than JAZZ.

Price Growth

JAZZ (@Biotechnology) experienced а -8.67% price change this week, while TPST (@Biotechnology) price change was -22.09% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.15%. For the same industry, the average monthly price growth was -16.20%, and the average quarterly price growth was -17.21%.

Reported Earning Dates

JAZZ is expected to report earnings on Jul 30, 2025.

TPST is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+0.15% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
JAZZ($6.1B) has a higher market cap than TPST($21.9M). JAZZ YTD gains are higher at: -18.392 vs. TPST (-42.665). JAZZ has higher annual earnings (EBITDA): 1.37B vs. TPST (-40.14M). TPST has less debt than JAZZ: TPST (15.4M) vs JAZZ (6.16B). JAZZ has higher revenues than TPST: JAZZ (4.07B) vs TPST (0).
JAZZTPSTJAZZ / TPST
Capitalization6.1B21.9M27,872%
EBITDA1.37B-40.14M-3,411%
Gain YTD-18.392-42.66543%
P/E Ratio11.80N/A-
Revenue4.07B0-
Total Cash2.99BN/A-
Total Debt6.16B15.4M40,013%
FUNDAMENTALS RATINGS
JAZZ vs TPST: Fundamental Ratings
JAZZ
TPST
OUTLOOK RATING
1..100
6383
VALUATION
overvalued / fair valued / undervalued
1..100
57
Fair valued
47
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
5697
PRICE GROWTH RATING
1..100
8097
P/E GROWTH RATING
1..100
8484
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TPST's Valuation (47) in the Pharmaceuticals Major industry is in the same range as JAZZ (57) in the Pharmaceuticals Other industry. This means that TPST’s stock grew similarly to JAZZ’s over the last 12 months.

TPST's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as JAZZ (100) in the Pharmaceuticals Other industry. This means that TPST’s stock grew similarly to JAZZ’s over the last 12 months.

JAZZ's SMR Rating (56) in the Pharmaceuticals Other industry is somewhat better than the same rating for TPST (97) in the Pharmaceuticals Major industry. This means that JAZZ’s stock grew somewhat faster than TPST’s over the last 12 months.

JAZZ's Price Growth Rating (80) in the Pharmaceuticals Other industry is in the same range as TPST (97) in the Pharmaceuticals Major industry. This means that JAZZ’s stock grew similarly to TPST’s over the last 12 months.

JAZZ's P/E Growth Rating (84) in the Pharmaceuticals Other industry is in the same range as TPST (84) in the Pharmaceuticals Major industry. This means that JAZZ’s stock grew similarly to TPST’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
JAZZTPST
RSI
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 2 days ago
79%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
53%
Bullish Trend 2 days ago
84%
Momentum
ODDS (%)
Bearish Trend 2 days ago
68%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 6 days ago
40%
Bearish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
56%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
60%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 11 days ago
63%
Bullish Trend 20 days ago
82%
Declines
ODDS (%)
Bearish Trend 2 days ago
56%
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
71%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
59%
Bearish Trend 2 days ago
89%
View a ticker or compare two or three
Ad is loading...
JAZZ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TPST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
VVR3.520.14
+4.14%
Invesco Senior Income Trust
OVS28.170.42
+1.51%
Overlay Shares Small Cap Equity ETF
DDIV34.670.50
+1.46%
First Trust Dorsey Wright Momt & Div ETF
UOCT33.900.42
+1.24%
Innovator U.S. Equity Ultra Buf ETF™ Oct
SHM47.02-0.09
-0.19%
SPDR® Nuveen Blmbg ST MunBd ETF

TPST and

Correlation & Price change

A.I.dvisor indicates that over the last year, TPST has been loosely correlated with PHIO. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if TPST jumps, then PHIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TPST
1D Price
Change %
TPST100%
+6.14%
PHIO - TPST
49%
Loosely correlated
+5.45%
ABCZF - TPST
48%
Loosely correlated
N/A
YMAB - TPST
35%
Loosely correlated
+11.03%
PRME - TPST
34%
Loosely correlated
+13.68%
JAZZ - TPST
34%
Loosely correlated
-1.52%
More